Objectives: The objectives of this study were to: estimate the prevalence of extended-spectrum b-lactamase (ESBL)-and AmpC b-lactamase-producing Escherichia coli carriage among broiler farmers, their family members and employees; identify and quantify risk factors for carriage, with an emphasis on contact with live broilers; and compare isolates from humans and broilers within farms with respect to molecular characteristics to gain insight into transmission routes.
Introduction
Extended-spectrum b-lactamase (ESBL)-and AmpC b-lactamaseproducing Enterobacteriaceae are frequently reported in broilers. 1, 2 This raises public health concerns as the intestinal microbiome of these animals might form a reservoir for ESBL/AmpC-encoding resistance genes, capable of being transmitted to humans. 3, 4 Transmission via the food chain has been suggested, 5, 6 but transmission resulting from close contact between humans and animals on livestock farms is also plausible. 2 Contact with live broilers has already been identified as a risk factor for methicillin-resistant Staphylococcus aureus (MRSA) carriage among humans. 7, 8 In the Netherlands, the prevalence of carriage of ESBL/ AmpC-producing Escherichia coli (hereafter referred to ESBL/ AmpC carriage) among broiler farmers was 33.3% (6/18), and b-lactamase genes located on identical plasmid families were detected in isolates from both farmers and their animals. 2 Furthermore, the prevalence among farmers was higher than that found among patients (4.9%) 5 and among humans not living on farms (5.1%) 9 in the Netherlands. This suggests that contact with broilers, and/or the farm environment, could be a risk factor for ESBL/AmpC carriage among humans. Risk factors for ESBL/AmpC carriage among people living and/ or working on broiler farms have not yet been reported. The objectives were therefore to estimate the prevalence among broiler farmers, their family members and employees, and to identify and quantify risk factors for carriage, with an emphasis on contact with live broilers. To gain an insight into transmission routes between broilers and humans, E. coli isolates from humans and broilers from the same farm were compared with respect to ESBL/AmpC genes, plasmid families and sequence types (STs).
Methods
From 5 July 2010 to 11 April 2011, a cross-sectional study of MRSA and ESBL/AmpC-producing bacteria was conducted on 50 Dutch broiler farms with 228 individuals living or working on these farms. Study populations were defined and sampled according to Geenen et al. 8 Participating farms had on average of three broiler houses (range 1-6; broilers of one age and using an all-in-all-out system), with a median number of broilers per farm of 78 000 (range 14 400 -200 000). The age of broilers at sampling was 21-49 days, with an average of 31 days. In order to accurately estimate the prevalence of ESBL/AmpC carriage among humans, given a prevalence of 33% among broiler farmers, a 95% confidence level and 10% accepted error, at least 85 individuals needed to be sampled.
Each farm was sampled by taking cloacal swabs from 20 broilers in total, the broilers being divided over all the broiler houses present on the farm. This sample size enables the detection of a positive farm at the 95% confidence level with a within-farm prevalence of at least 14%. The study was performed according to Dutch law on studies with animals. Farmers, family members and employees who voluntarily participated in the study returned an informed consent form, a faecal swab and a questionnaire on their lifestyle and health characteristics. For children aged ,18 years parental consent was requested. Farmers also completed a questionnaire on the farm (management) characteristics. The median time between the sampling of broilers and the arrival of human samples was 1 day (range 0 -28 days).
Broiler samples were pooled into 10 pools of two swabs each; human samples were examined individually. Bacteria were isolated by selective enrichment (Luria-Bertani broth with 1 mg/L of cefotaxime) and cultured on selective plates for 18 h at 378C (MacConkey agar no. 3 with 1 mg/L of cefotaxime). E. coli-like, indole-positive isolates (five isolates per human sample and 10 isolates per broiler farm) were tested phenotypically for ESBL production by combination disc diffusion test according to CLSI guidelines. 10 A cefoxitin disc was used to detect the AmpC phenotypes. E. coli phylogenetic groups were determined for a minimum of one (range 1 -3) isolate per person testing positive as reported by Clermont et al. 11 and Escobar-Pá ramo et al. 12 E. coli was confirmed in isolates that were negative for all three amplicons as described by Frahm and Obst. 13 Subsequently, phylogenetic groups were determined for a minimum of one (range 1 -9) positive broiler isolate from each farm with human ESBL/AmpC carriage. More than one isolate per human or broiler was included if there were differences in the disc diffusion test indicative of the presence of different ESBL/AmpC genes.
b-Lactamase genes were identified by PCR and sequencing in line with Dierikx et al.
14 If broiler and human isolates showed similar E. coli phylogenetic groups and/or ESBL/AmpC genes within the same farm, multilocus sequence typing (MLST) of E. coli was performed as described by Wirth et al. 15 Plasmid characterization was performed for a selection of isolates representing the diversity of ESBL/AmpC genes in humans and broilers, and on isolate pairs with the same E. coli ST and ESBL/AmpC gene by transformation and PCR-based replicon typing as described by Hordijk et al. 16 and Carattoli et al.
17
Prevalences and their exact 95% CIs were calculated based on the binomial probability function. Risk factor analysis could not be conducted at the farm level as all the farms were classified as positive (i.e. bacteria were phenotypically characterized as ESBL/AmpC-producing E. coli in at least one broiler sample). To assess the relationship between ESBL/AmpC carriage among humans and possible risk factors, univariable and multivariable logistic regression analyses were performed for the variables in Table 1 as reported by Hosmer and Lemeshow. 18 As observations on the same farm might not have been independent, a random effect of farms was included using an exchangeable covariance structure.
Results and discussion
This study investigates ESBL/AmpC carriage among not only farmers, but also all individuals living and/or working on broiler farms and is the first study reporting risk factors for carriage. Faecal swabs and informed consent forms were provided by 141/228 individuals from 47 farms (a response rate of 61.8%). An average of three individuals per farm (range 1 -9) was included, with an average age of 36.6 years (SD 19.1, range 1 -80). Similar to the results of Dierikx et al.,
2 ESBL/AmpC-producing E. coli were present in broilers on all 50 farms, with a pooled sample prevalence of 96.4% (482/500; 95% CI 94.4% -97.9%). In total, 27 humans originating from 21 farms tested positive (19.1%; 95% CI 13.0% -26.6%). The prevalence in farmers (25.5%; exact 95% CI 13.9% -40.4%) and employees (37.5%; exact 95% CI 8.5% -75.5%) was similar to that of Dierikx et al. 2 (33.3%). The prevalence in partners (11.4%; exact 95% CI 3.2% -26.7%) and family members (15.7%; exact 95% CI 7.0% -28.6%) was lower than in farmers and employees, but still higher in comparison with patients and the general population. 5, 9 It was hypothesized that a high degree of contact with live broilers could be a risk factor for human ESBL/AmpC carriage on broiler farms. Information about the number of hours per week present in the broiler house and the number of hours per week having physical contact with live broilers was completed by about half of the participants (by 81 and 77 individuals, respectively). Analysis of variance of these variables showed that farmers (2.8 h and 1.8 h) and employees (1.8 h and 0.6 h) had a significantly higher degree of contact (P,0.0001) compared with partners (0.7 h and 0.5 h) and other family members (0.3 h and 0.1 h). In addition individuals reporting the performance of activities in the broiler house (i.e. weighing, vaccination, blood sampling and/or health checks) were more often (x 2 P, 0.0001) farmers and employees (98.1%) than partners and family members (33.8%). Based on this information a new variable ('contact with broilers') was created, with farmers and employees in one category and partners and family members in the other. ESBL/ AmpC carriage among humans related to possible risk factors are shown in Table 1 . Sex, age, hours spent in the broiler house, performance of activities in the broiler house and type of person correlated strongly (.0.5) with the 'contact with broilers' variable. To avoid multicollinearity only the latter variable was included in the multivariable model. Three out of the seven initially included variables (Table 1 ) remained in the final multivariable model, in which the random farm effect explained 8% of the non-explained variation. In this model, based on 118 individuals with a complete record, farmers and employees were at a higher risk of ESBL/ AmpC carriage than partners and family members (27.1% versus 14.3%; OR¼2.5; P¼0.08). It seems that there is an increased risk 19 and antibiotic use 20 were not identified in the current study. The similarity of answers to the questionnaire, which resulted in categories with ,10% of available data, makes it difficult, however, to draw statistically valid conclusions on these risk factors.
The distribution of phylogenetic groups, ESBL/AmpC genes and plasmids for a selection of 43 human and 90 broiler E. coli isolates from 21 farms with humans testing positive is summarized in Table 2 . The molecular characteristics of all the isolates are presented in Table S1 (available as Supplementary data at JAC Online). Phylogenetic groups A 0 , A 1 , B1 1 , and D 2 predominated both in humans and in broilers. The most prevalent genes in isolates from humans as well as broilers were bla CMY-2, bla CTX-M-1 and bla SHV-12 , and the most recovered plasmid family was IncI1 ( Table 2 ). The similarity of distribution of the phylogenetic groups, ESBL/AmpC genes and plasmid families in human isolates compared with broiler isolates suggests an exposure to a local pool of resistance genes related to broilers and the farm environment. This is further supported by the fact that bla CTX-M-15 , which is one of the most prevalent genes found in humans in the Netherlands, 5, 21 was not found in the present study. In addition, bla SHV-12 and bla CMY-2 predominated but these are only found sporadically in isolates from patients 5, 6 and the community. 21 MLST was performed for a selection of human and broiler isolates from 12 farms (Table 3) . On the other nine farms with humans testing positive (Table S1) , ESBL/AmpC genes and/or E. coli phylogenetic groups were not similar between humans and broilers so MLST was not performed. In five cases, broilerhuman isolate pairs showed the same ESBL/AmpC gene, plasmid family and E. coli ST (Table 3) . Given the epidemiological relatedness of isolates collected in this study, a clonal transfer of ESBL/AmpC-producing E. coli between broilers and humans is likely. The ST diversity observed in the current study and by Dierikx et al. 2 further suggests that finding these broiler -human isolate pairs is not a coincidence. Clonal transfer is only the starting point for transmission as horizontal gene transfer 3,4 may occur within bacterial populations, e.g. between E. coli with different STs and between E. coli and other bacterial species. Focusing on clonal transfer alone will therefore underestimate the frequency of transfer. In the current study identical ESBL/AmpC genes located on the same plasmid family were found in different E. coli STs (Table 3 ; farms 10, 12 and 16), suggesting a horizontal transfer of plasmids via conjugation between different E. coli strains.
Transmission between humans and broilers has been shown but knowledge about the (relative) contribution of transmission routes that might play a role in the dissemination of ESBL/AmpC-encoding resistance genes is lacking. Direct contact between humans and live broilers seems to play a major role, given the highest prevalence in farmers and employees. It is important, however, also to consider transmission via the farm environment and between humans within the household, given the relatively high prevalence in family members. E. coli have a high survival rate in the environment, which might lead to the accumulation of these bacteria, 22 both inside and outside the broiler house, and indirect transmission to individuals living on farms. Environmental samples were not collected in the current study. A high rate of intestinal colonization with ESBL-producing organisms was shown for the household members of patients suffering from community-acquired urinary tract infections, and up to 66.6% of isolates from case patients and their corresponding household members had indistinguishable PFGE patterns. 23 In the current study two isolates were found, one from a farmer and one from a family member, from the same farm with bla CMY-2 , located on a plasmid from the incI1 family, in an E. coli with ST117, which might indicate human-to-human transmission. The family member reported no contact with live broilers and rarely entered the broiler house.
This study contributes to the growing body of evidence supporting the risk for humans working and/or living on broiler In an 'intercept only' model (without explanatory variables) the random farm effect was not significant and explained only 1.9% of the non-explained variation. b A number of questionnaires were not complete, resulting in variables with missing values. c Variables with a P value (based on the likelihood ratio test) in bold (P, 0.25) were considered for multivariable modelling. d Activities in the broiler house include weighing, vaccination, blood sampling and health checks. e Skin diseases include psoriasis, eczema, impetigo, infected skin, infected wounds and boils.
Huijbers et al. a A number of genes were found in combination with TEM-1b [CMY-2 (n ¼ 8), CTX-M-1 (n ¼ 10), CTX-M-2 (n ¼2), CTX-M-32 (n ¼ 1), SHV-12 (n ¼ 8) and TEM-52 (n¼5)]; see Table S1 . One TEM-52 isolate was found with one mutation (C228T) and 11 TEM-52 isolates were found with three mutations (C18T, C228T and G396T) in this gene. With the primers used in this study no distinction was made between TEM-1b and TEM-198; however, for readability of the table, TEM-1b was inserted. c MLST results: adk35, fumC3, gyrB234, icd342 mdh45, purA5, recA95. d Isolates were found with three mutations (C18T, C228T and G396T). All were synonymous mutations.
